Jennitte L. Stevens, Ph.D.
Affiliations: | 2002 | University of California, Los Angeles, Los Angeles, CA |
Area:
Molecular Biology, GeneticsGoogle:
"Jennitte Stevens"Parents
Sign in to add mentor| Arnold J. Berk | grad student | 2002 | UCLA | |
| (Genetic characterization of the mediator subunit Sur2 provides insight to metazoan mediator function.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Spahr CS, Daris ME, Graham KC, et al. (2018) Discovery, characterization, and remediation of a C-terminal Fc-extension in proteins expressed in CHO cells. Mabs |
| Shi SY, Lu YW, Liu Z, et al. (2018) A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity. The Journal of Biological Chemistry |
| Wu X, Weiszmann J, Ge H, et al. (2012) A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho. Journal of Molecular Biology. 418: 82-9 |
| Yie J, Wang W, Deng L, et al. (2012) Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signaling. Chemical Biology & Drug Design. 79: 398-410 |
| Shalhoub V, Ward SC, Sun B, et al. (2011) Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization. Calcified Tissue International. 89: 140-50 |
| Zhang M, Howard K, Winters A, et al. (2011) Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis, but not trans, format relative to the activating stimulus. Clinical and Experimental Immunology. 163: 77-87 |
| Balamotis MA, Pennella MA, Stevens JL, et al. (2009) Complexity in transcription control at the activation domain-mediator interface. Science Signaling. 2: ra20 |
| Yie J, Hecht R, Patel J, et al. (2009) FGF21 N- and C-termini play different roles in receptor interaction and activation. Febs Letters. 583: 19-24 |
| Balamotis MA, Pennella MA, Stevens JL, et al. (2009) Erratum: Complexity in transcription control at the activation domain-mediator interface (Science Signaling (2009) 89 (er8)) Science Signaling. 2 |
| Wu X, Lemon B, Li X, et al. (2008) C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors. The Journal of Biological Chemistry. 283: 33304-9 |